Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas”.
Paola Ghione, Eric D. Jacobsen, Jia Ruan, Jonathan H. Schatz, Sarah Noor +31 more
Phillip Comella, Esther Cheng, Lauren Lepow, Aviva G. Beckmann, Scott R. Tyler +94 more